Cargando…

Effect of Thio-TEPA on Advanced Malignant Ovarian Tumours

Detalles Bibliográficos
Autores principales:	Englander, O., Sarangi, A.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1960
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074142/ https://www.ncbi.nlm.nih.gov/pubmed/13820375

Ejemplares similares

6th International TEPA Symposium : Thunderstorms and Elementary Particle Acceleration
por: Chilingarian, A
Publicado: (2017)

5th International TEPA Symposium : Thunderstorms and Elementary Particle Acceleration
por: Chilingarian, A
Publicado: (2016)

Controllable Synthesis of Tetraethylenepentamine Modified Graphene Foam (TEPA-GF) for the Removal of Lead ions
por: Han, Zhuo, et al.
Publicado: (2015)

TEPA impregnation of electrospun carbon nanofibers for enhanced low-level CO(2) adsorption
por: Wang, Jie, et al.
Publicado: (2020)

Electrospun Nanofibrous Membranes Based on Citric Acid-Functionalized Chitosan Containing rGO-TEPA with Potential Application in Wound Dressings
por: Cojocaru, Elena, et al.
Publicado: (2022)

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.
por: van der Zee, A. G., et al.
Publicado: (1992)

Immunohistochemical profiling of the tumour microenvironment in borderline and malignant ovarian tumours in young women
por: O'Neill, Danielle, et al.
Publicado: (2023)

Glutathione S-transferase expression in benign and malignant ovarian tumours.
por: Green, J. A., et al.
Publicado: (1993)

Ovarian tuberculosis mimicking a malignant tumour
por: Yebouet, Eric, et al.
Publicado: (2015)

Malignant ovarian tumours in childhood in Britain, 1962-78.
por: La Vecchia, C., et al.
Publicado: (1983)

A New Model for Inducing Malignant Ovarian Tumours in Rats*
por: Hilfrich, J.
Publicado: (1973)

Expression of cyclin D1 correlates with malignancy in human ovarian tumours.
por: Barbieri, F., et al.
Publicado: (1997)

Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours.
por: Wilson, K. E., et al.
Publicado: (1996)

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression
por: Tuhkanen, Hanna, et al.
Publicado: (2009)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours
por: Saani, Iqra, et al.
Publicado: (2023)

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
por: Huhtinen, K, et al.
Publicado: (2009)

Malignant ovarian mixed germ cell tumour: a rare combination
por: Koshy, M, et al.
Publicado: (2005)

Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours
por: Szala, Agnieszka, et al.
Publicado: (2013)

MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue.
por: Gillespie, A. M., et al.
Publicado: (1998)

Gene expression profiling of epithelial ovarian tumours correlated with malignant potential
por: Warrenfeltz, Susanne, et al.
Publicado: (2004)

Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours
por: Liu, Guohui, et al.
Publicado: (2019)

Hedinger syndrome due to advanced malignant neuroendocrine tumour
por: Ackerschott, Ansgar, et al.
Publicado: (2023)

Advances in Superprocesses and Nonlinear PDEs
por: Englander, Janos, et al.
Publicado: (2013)

Progesterone in the Treatment of Advanced Malignant Tumours of Breast, Ovary and Uterus*
por: Jolles, B.
Publicado: (1962)

Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas
por: Yu, J, et al.
Publicado: (2007)

Tumour antigenicity in ovarian cancer.
por: Levin, L., et al.
Publicado: (1975)

Editorial: The advances in proteomics and targeted therapy of malignant brain tumours
por: Chen, Anjing, et al.
Publicado: (2023)

Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo
por: Kauppila, S, et al.
Publicado: (1999)

Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial
por: Dochez, Vincent, et al.
Publicado: (2019)

Malignant tumours of the salivary glands
por: Bensadoun, R J, et al.
Publicado: (2001)

Tumour to Tumour Metastasis of Malignant Melanoma to Intracranial Tumour
por: Shariff, Zakir, et al.
Publicado: (2009)

Malignant tumours in Malaya.
por: Ahluwalia, H. S., et al.
Publicado: (1966)

International Histological Classification of Tumours, No. 9. Histological Typing of Ovarian Tumours
por: Dodge, O. G.
Publicado: (1974)

Ovarian Tumours and Ovariotomy
Publicado: (1873)

Size of Ovarian Tumours
por: Green, C. R. M.
Publicado: (1900)

Effect of radiation on nuclear phosphorylation in human malignant tumours.
por: Fahmy, A. R., et al.
Publicado: (1965)

Advanced Ovarian Cancer during Pregnancy. Tumour Evolution Analysis and Treatment Approach
por: Bueno Moral, Ana Isabel, et al.
Publicado: (2021)

(Thiocyanato-κS)tris(thiourea-κS)mercury(II) chloride
por: Shihabuddeen Syed, A., et al.
Publicado: (2013)

“Malignant Brain Tumours.”
por: Byrnes, D P
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_3cl8cq6hn5nj776vep8s1liih3